TY - JOUR
T1 - Risk factors for mortality due to bacteremia and fungemia in childhood
AU - Ashkenazi, Shai
AU - Leibovici, Leonard
AU - Samra, Zmira
AU - Konisberger, Hanna
AU - Drucker, Moshe
N1 - Funding Information:
Received 18 July 1991; revised 20 November 1991. Grant support: This study was supported in part by Glaxo Laboratories, Greenford, Middlesex, England. Reprints or correspondence: Dr. Shai Ashkenazi, Department of Pediatrics, Beilinson Medical Center, Petah Tiqva 49 100. Israel.
PY - 1992/4/1
Y1 - 1992/4/1
N2 - To define risk factors for mortality due to bacteremia and fungemia of childhood, 242 episodes (for which the mortality rate was 19%) were studied prospectively by univariate and multivariate analyses. The mortality rate was higher in neonates (23%) and in individuals 10-18 years old (26%) than in infants and young children (10%-16%). The mortality rate was 29% for children who had neutropenia, 29% for those who had received therapy with steroids, 26% for those who had received antibiotics, and 75% for those who were in septic shock. The fatality rates for polymicrobial bacteremia (40%), recurrent bacteremia (67%), and hospital-acquired bacteremia (28%) were higher than those for other types of bacteremia; the fatality rate was related to inappropriate empiric antibiotic treatment or to the specific organism isolated (mortality rates associated with the latter ranged from 0 to 60%). Seven variables that independently and significantly affected mortality were defined with use of multivariate logistic regression analysis: septic shock (odds ratio [OR], 26.4); polymicrobial (OR, 5.4), recurrent (OR, 4.5), or hospital-acquired (OR, 4.3) bacteremia; candidemia (OR, 3.6); inappropriate antibiotic treatment (OR, 2.4); and neutropenia (OR, 2.3). These variables should be considered for adequate management of bacter- emic patients who are at high risk for death.
AB - To define risk factors for mortality due to bacteremia and fungemia of childhood, 242 episodes (for which the mortality rate was 19%) were studied prospectively by univariate and multivariate analyses. The mortality rate was higher in neonates (23%) and in individuals 10-18 years old (26%) than in infants and young children (10%-16%). The mortality rate was 29% for children who had neutropenia, 29% for those who had received therapy with steroids, 26% for those who had received antibiotics, and 75% for those who were in septic shock. The fatality rates for polymicrobial bacteremia (40%), recurrent bacteremia (67%), and hospital-acquired bacteremia (28%) were higher than those for other types of bacteremia; the fatality rate was related to inappropriate empiric antibiotic treatment or to the specific organism isolated (mortality rates associated with the latter ranged from 0 to 60%). Seven variables that independently and significantly affected mortality were defined with use of multivariate logistic regression analysis: septic shock (odds ratio [OR], 26.4); polymicrobial (OR, 5.4), recurrent (OR, 4.5), or hospital-acquired (OR, 4.3) bacteremia; candidemia (OR, 3.6); inappropriate antibiotic treatment (OR, 2.4); and neutropenia (OR, 2.3). These variables should be considered for adequate management of bacter- emic patients who are at high risk for death.
UR - http://www.scopus.com/inward/record.url?scp=0026519728&partnerID=8YFLogxK
U2 - 10.1093/clinids/14.4.949
DO - 10.1093/clinids/14.4.949
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 1576293
AN - SCOPUS:0026519728
SN - 1058-4838
VL - 14
SP - 949
EP - 951
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 4
ER -